Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 clinical trial evaluating ultrasound-induced opening of the blood-brain barrier in combination with albumin-bound paclitaxel and carbop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abraxane (albumin-bound paclitaxel) (paclitaxel protein-bound albumin)
  • CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Northwestern University | Conditions: Glioblastoma, Gliosarcoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING